PMCCPMCCPMCC

Search tips
Search criteria 

Advanced


 
Formats
Article sections
Authors
Related links
Logo of bmccancBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Cancer
 
BMC Cancer. 2011; 11: 364.
Published online 2011 August 22. doi:  10.1186/1471-2407-11-364
PMCID: PMC3178543
Copyright ©2011 Li et al; licensee BioMed Central Ltd.
A Nation-Wide multicenter 10-year (1999-2008) retrospective clinical epidemiological study of female breast cancer in china
Jing Li,1 Bao-Ning Zhang,2 Jin-Hu Fan,1 Yi Pang,1,11 Pin Zhang,3 Shu-Lian Wang,4 Shan Zheng,5 Bin Zhang,6 Hong-Jian Yang,7 Xiao-Ming Xie,8 Zhong-Hua Tang,9 Hui Li,10 Jia-Yuan Li,11 Jian-Jun He,12 and You-Lin Qiaocorresponding author1
1Dept. of Cancer Epidemiology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 17 South Panjiayuan Lane, Beijing 100021, China
2Center of Breast Disease, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 17 South Panjiayuan Lane, Beijing 100021, China
3Dept. of Medical Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 17 South Panjiayuan Lane, Beijing 100021, China
4Dept. of Radiation Oncology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 17 South Panjiayuan Lane, Beijing 100021, China
5Dept. of Pathology, Cancer Institute & Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, 17 South Panjiayuan Lane, Beijing 100021, China
6Dept. of Breast Surgery, Liaoning Cancer Hospital, No. 44 Xiaoyanhe Road, Dadong District, Shenyang 110042, China
7Dept. of Breast Surgery, Zhejiang Cancer Hospital, No. 38 Banshanqiao Guanji Road, Hangzhou 310022, China
8Dept. of Breast Oncology, Sun Yat-Sen University Cancer Center, 651 Dongfeng East, Gungzhou 510060, China
9Dept. of Breast-thyroid Surgery, Xiangya Sencod Hospital, Central South University, No. 139 Renminzhonglu, Changsha 410011, China
10Dept. of Breast Surgery, the Second People's Hospital of Sichuan Province, Chengdu 610041, China
11Dept. of Epidemiology, West China School of Public Health, Sichuan University, Chengdu, Sichuan 610041, China
12Dept. of Oncosurgery, the First Affiliated Hospital of Medical College, Xi'an JiaoTong University, 277 Yanta West Road, Xi'an 710061, China
corresponding authorCorresponding author.
Jing Li: leej/at/cicams.ac.cn; Bao-Ning Zhang: cbd8891/at/126.com; Jin-Hu Fan: fjhjjj/at/sohu.com; Yi Pang: pangyi_cc/at/163.com; Pin Zhang: zhang_pin/at/sina.com; Shu-Lian Wang: wsl20040118/at/yahoo.com; Shan Zheng: zhengshan1002/at/yahoo.com.cn; Bin Zhang: zhangbin/at/medmail.com.cn; Hong-Jian Yang: yhjzlyy/at/163.com; Xiao-Ming Xie: xxie1234/at/yahoo.com; Zhong-Hua Tang: tzh2020158/at/sina.com; Hui Li: zlyy_lh/at/163.com; Jia-Yuan Li: Lijiayuan73/at/163.com; Jian-Jun He: chinahjj/at/163.com; You-Lin Qiao: Qiaoy/at/cicams.ac.cn
Received May 11, 2011; Accepted August 22, 2011.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Small right arrow pointing to: This article has been cited by other articles in PMC.
Abstract
Background
According to the very limited cancer registry, incidence and mortality rates for female breast cancer in China are regarded to be increasing especially in the metropolitan areas. Representative data on the breast cancer profile of Chinese women and its time trend over years are relatively rare. The aims of the current study are to illustrate the breast cancer profile of Chinese women in time span and to explore the current treatment approaches to female breast cancer.
Methods
This was a hospital-based nation-wide and multi-center retrospective study of female primary breast cancer cases. China was divided into 7 regions according to the geographic distribution; from each region, one tertiary hospital was selected. With the exception of January and February, one month was randomly selected to represent each year from year 1999 to 2008 at every hospital. All inpatient cases within the selected month were reviewed and related information was collected based on the designed case report form (CRF). The Cancer Hospital/Institute, Chinese Academy of Medical Sciences (CICAMS) was the leading hospital in this study.
Results
Four-thousand two-hundred and eleven cases were randomly selected from the total pool of 45,200 patients and were included in the analysis. The mean age at diagnosis was 48.7 years (s.d. = 10.5 yrs) and breast cancer peaked in age group 40-49 yrs (38.6%). The most common subtype was infiltrating ductal carcinoma (86.5%). Clinical stage I & II accounted for 60.6% of 4,211 patients. Three-thousand five-hundred and thirty-four cases had estrogen receptor (ER) and progestin receptor (PR) tests, among them, 47.9% were positive for both. Two-thousand eight-hundred and forty-nine cases had human epidermal growth factor receptor 2(HER-2) tests, 25.8% of them were HER-2 positive. Among all treatment options, surgery (96.9% (4,078/4,211)) was predominant, followed by chemotherapy (81.4% (3,428/4,211). Much less patients underwent radiotherapy (22.6% (952/4,211)) and endocrine therapy (38.0% (1,599/4,211)).
Conclusions
The younger age of breast cancer onset among Chinese women and more advanced tumor stages pose a great challenge. Adjuvant therapy, especially radiotherapy and endocrine therapy are of great unmet needs.
Articles from BMC Cancer are provided here courtesy of
BioMed Central